【Hot Spots】
Aoya shares: At present, the company does not have the technical patent accumulation required to carry out intelligent computing business and the operational qualifications required to carry out intelligent computing business
Aoya shares (300949) on the evening of December 20 issued an announcement on abnormal fluctuations in stock trading, at present, the company does not have the technical patent accumulation required to carry out intelligent computing business and the operational qualifications required to carry out intelligent computing business, and in the early stage of the project, business development needs other IDC infrastructure operation and maintenance, network security and other partners to support. Other difficulties, uncertainties or risks that may exist in the process of contract execution in terms of laws and regulations, performance capacity, technology, production capacity, market, price, exchange rate, etc.
Emdoor information: the company's MR products are still in the market promotion stage, and the XR business accounts for a relatively small proportion of the company's overall revenue
Emdoor Information (001314) issued an announcement on the evening of December 20 on abnormal fluctuations in stock trading, the company is concerned that the recent MR-related concepts have received high market attention, the company's MR products are still in the market promotion stage, and the XR business accounts for a relatively small proportion of the company's overall revenue.
Baotou Iron and Steel Co., Ltd.: The controlling shareholder's total control index of rock-mineral rare earth oxide mining in 2023 will increase significantly year-on-year
Baotou Iron and Steel Co., Ltd. (600010) announced on the evening of December 20 that the total control index of rock and mineral rare earth oxide mining obtained by Baotou Iron and Steel Group, the controlling shareholder of the company, in 2023 will increase significantly compared with 2022, with an increase of 26.12%. The company will continue to promote the use of Baiyun Obo resources as raw materials and the use of rare earth beneficiation production lines to increase the production of rare earth concentrates.
Yatong shares: The company's land properties in Chongming North Qiji and North Liuxiao are all basic farmland
On December 20, 600692 the People's Government of Chongming District, Shanghai issued the "Administrative Measures for the Entry of Rural Collective Construction Land into the Market in Chongming District, Shanghai (Trial)", and investors have recently consulted the impact of the measures on the company. The company has 1,101,036.00 square meters and 605,851.00 square meters of agricultural land in Chongming North Qiji and North Liuxiao respectively, which belong to basic farmland and do not belong to the category of rural collective management construction land stipulated in the measures.
【M&A】
Chinese Media: Plans to acquire the equity of Jiangjiao Media and University Press, and the stock will resume trading
Chinese Media (600373) announced on the evening of December 20 that the company intends to acquire 100% of the shares of Jiangjiao Media and 51% of the shares of University Press held by the publishing group by issuing shares and paying cash. Up to now, the audit and evaluation work involved in this transaction has not been completed. After the completion of the transaction, Jiangjiao Media and University Press will become wholly-owned subsidiaries of the company, further enhancing the scale and market competitiveness of the listed company's publishing and distribution business in the field of juvenile publications, teaching materials and teaching aids, and enhancing its ability to continue operations. The company's shares have resumed trading since the market opened on December 21.
*ST Mall: It is planned to purchase 7.24% of the partnership share of Hailiao Investment for 90 million yuan
*ST Mall (600306) announced on the evening of December 20 that in order to obtain investment income through investment in integrated circuit materials projects, the company intends to purchase 7.24% of Yantai Hailiao Integrated Circuit Industry Investment Center (Limited Partnership) (hereinafter referred to as "Hailiao Investment") held by Yang Xiaohua with its own funds or self-raised funds of 90 million yuan Partnership share (corresponding to the subscribed capital contribution of 83,303,996 yuan, and the paid-in capital contribution of 77,074,306 yuan), and become a limited partner of the partnership.
【Business Performance】
Nanqiao Food: Net profit in November was 31.4275 million yuan, an increase of 454.99% year-on-year
Nanqiao Food (605339) announced on the evening of December 20 that the company's net profit attributable to shareholders of the parent company in November 2023 was 31.4275 million yuan, a year-on-year increase of 454.99%.
China Mobile: The number of mobile business customers increased by 171,000 in November
China Mobile (600941) announced on the evening of December 20 that the total number of mobile service customers in November was 990.948 million, a net increase of 171,000, including 778.8 million 5G package customers.
China Telecom: The number of mobile subscribers increased by 590,000 in November
China Telecom (601728) announced on the evening of December 20 that the number of mobile users in November was 407.23 million, a net increase of 590,000 in the month, of which 314.63 million were 5G package users.
[Increase, decrease, repurchase, etc.]
Xiamen Tungsten: The indirect controlling shareholder plans to increase its holdings of the company's shares by 50 million yuan to 100 million yuan
Xiamen Tungsten Industry (600549) announced on the evening of December 20 that Fujian Metallurgy, the company's indirect controlling shareholder, plans to increase its holdings of the company's shares within 6 months from December 25, with a cumulative increase of not less than 50 million yuan and no more than 100 million yuan. There is no price range for this increase plan.
Espressif Technology: It plans to repurchase the company's shares for 40 million yuan to 80 million yuan
Espressif Systems (688018) announced on the evening of December 20 that it plans to use the company's own funds to repurchase the company's shares for 40 million to 80 million yuan for employee stock ownership or equity incentive plans. The repurchase price does not exceed 120 yuan per share.
Xiamen Tungsten New Energy: It is planned to repurchase shares for 30 million yuan to 50 million yuan
Xiamen Tungsten New Energy (688778) announced on the evening of December 20 that the company is planning to repurchase the company's shares, which will be used for employee stock ownership plans or equity incentives at an appropriate time in the future, and the total amount of funds to repurchase shares shall not be less than 30 million yuan and not more than 50 million yuan.
Zhenghai Biological: It is planned to repurchase the company's shares for 25 million yuan to 50 million yuan
Zhenghai Biology (300653) announced on the evening of December 20 that it intends to use its own funds to repurchase the company's shares for equity incentives or employee stock ownership plans with 25 million yuan to 50 million yuan through centralized bidding, and the repurchase price does not exceed 44.90 yuan per share.
Hongyuan Electronics: It is planned to repurchase shares for 20 million yuan to 30 million yuan
Hongyuan Electronics (603267) announced on the evening of December 20 that the company intends to repurchase the company's A shares to maintain the company's value and shareholders' rights, and the proposed repurchase price does not exceed 80 yuan per share, and the total amount of funds to be used for repurchase is not less than 20 million yuan and not more than 30 million yuan.
Jingye Intelligence: It is planned to repurchase shares for 20 million yuan to 30 million yuan
Jingye Intelligent (688290) announced on the evening of December 20 that the company intends to repurchase shares with no less than 20 million yuan and no more than 30 million yuan, which is intended to be used for employee stock ownership plans or equity incentives at an appropriate time in the future.
Xinao shares: one of the actual controllers intends to increase its holdings of the company's shares by 15 million yuan to 30 million yuan
Xinao shares (603889) announced on the evening of December 20 that Shen Jiafeng, the actual controller of the company and the son of Chairman Shen Jianhua, increased his holdings of 1.0888 million shares of the company's A shares through centralized bidding on the Shanghai Stock Exchange on December 20, accounting for 0.15% of the company's total share capital. Shen Jiafeng intends to increase his holdings of the company's shares in the next 6 months from December 20 through the methods permitted by the Shanghai Stock Exchange (including but not limited to centralized bidding and block trading, etc.), and the cumulative amount of the proposed additional shares shall not be less than 15 million yuan and not more than 30 million yuan.
Zhuoyi Information: The actual controller proposed that the company repurchase shares for 10 million yuan to 20 million yuan
Zhuoyi Information (688258) announced on the evening of December 20 that Xie Qian, the company's chairman, controlling shareholder, actual controller and general manager, proposed that the company repurchase shares in a centralized bidding transaction, with a total repurchase fund of not less than 10 million yuan and no more than 20 million yuan, and the repurchased shares will be used for the company's employee equity incentive or employee stock ownership plan.
Jinlv Environment: It is planned to repurchase the company's shares for 5 million yuan to 10 million yuan
Jinlv Environment (001230) announced on the evening of December 20 that the company intends to use its own funds to repurchase the company's shares with 5 million yuan to 10 million yuan through centralized bidding transactions for employee stock ownership plans or equity incentives. The repurchase price shall not exceed 34 yuan per share.
Nanxin Pharmaceutical: It plans to repurchase shares for 5 million yuan to 10 million yuan
Nanxin Pharmaceutical (688189) announced on the evening of December 20 that the company intends to repurchase part of the company's shares in a centralized bidding transaction, and the repurchased shares will be used for equity incentives or employee stock ownership plans at an appropriate time in the future. The total amount of repurchase funds shall not be less than 5 million yuan and not more than 10 million yuan, and the repurchase price shall not exceed 15.85 yuan per share.
INTCO Medical: The chairman, controlling shareholder and actual controller intends to increase his holdings of no less than 10 million yuan of the company's shares
INTCO Medical (300677) announced on the evening of December 20 that Liu Fangyi, chairman, controlling shareholder and actual controller, plans to increase his holdings of no less than 10 million yuan of the company's shares based on his confidence in the company's future development and recognition of the long-term investment value, and the source of funds required for the increase is its own/self-raised funds. The shareholding increase plan does not set a price range for the increase in shares.
Yingke Regeneration: The actual controller intends to increase his holdings of the company's shares by 4 million yuan to 8 million yuan
Yingke Regeneration (688087) announced on the evening of December 20 that Liu Fangyi, the actual controller and chairman of the company, intends to use his own funds or self-raised funds to increase his holdings of the company's shares within six months from December 21 through the methods allowed by the Shanghai Stock Exchange system (including but not limited to centralized bidding, block trading, etc.), and the amount of this increase is not less than 4 million yuan and not more than 8 million yuan.
Radio and Television Network: The management intends to increase its holdings of no less than 600,000 yuan of the company's shares
Radio and Television Network (600831) announced on the evening of December 20 that 11 members of the company's management plan to increase their holdings of the company's A shares by a total of not less than 600,000 yuan through the securities trading system of the Shanghai Stock Exchange from December 21 to December 29.
Haineng Industrial: Shareholders plan to reduce their holdings of no more than 1.9686% of the company's shares
Haineng Industry (300787) announced on the evening of December 20 that shareholders Dasheng Investment intends to reduce their holdings of no more than 1.2 million shares of the company, Hesheng Investment intends to reduce their holdings of no more than 1 million shares of the company, Li Weixiong and his concerted action Li Dongyi plan to reduce their holdings of no more than 1% of the company's shares, and the above shareholders plan to reduce their holdings of no more than 1.9686% of the company's shares.
CICC Irradiation: Shareholders intend to reduce their holdings of no more than 1% of the company's shares in total
CICC Irradiation (300962) announced on the evening of December 20 that shareholders Gongqingcheng Xinwei Investment Management Partnership (Limited Partnership) intend to reduce their holdings of no more than 0.55% of the company's shares, and Gongqingcheng Xingang Investment Management Partnership (Limited Partnership) intends to reduce their holdings of no more than 0.45% of the company's shares, and the above shareholders plan to reduce their holdings of no more than 1% of the company's shares in total.
Jixin Technology: Shareholders plan to reduce their holdings of the company's shares by no more than 1%
Jixin Technology (601218) announced on the evening of December 20 that Zhang Jinyu, a shareholder of the company holding 5.0307% of the company's shares, plans to reduce his holdings of the company's shares by centralized bidding from January 16, 2024 to April 15, 2024 from January 16, 2024 to April 15, 2024, and the proportion of shares to be reduced does not exceed 1% of the company's total share capital, and the reduction price is determined according to the market price.
Hangyu Micro: Shareholder Wu Yuqi plans to reduce his holdings of no more than 0.4771% of the company's shares
Hangyu Micro (300053) announced on the evening of December 20 that Wu Yuqi, a shareholder who holds 1.91% of the company's shares, intends to reduce his holdings of no more than 0.4771% of the company's shares.
Dawson shares: shareholders plan to reduce their holdings of the company's shares by no more than 100,000 shares
Dawson shares (603800) announced on the evening of December 20 that Chen Delin, a shareholder of 5.01% of the shares, intends to reduce his holdings of the company's shares by centralized bidding within 3 months after 15 trading days from the date of disclosure of this announcement, accounting for about 0.0481% of the company's total share capital.
【Refinancing】
Li Tong Electronics: It is planned to raise no more than 650 million yuan for the construction of ferrite device production lines and other projects
Li Tong Electronics (603629) announced on the evening of December 20 that the company intends to issue shares to specific objects to raise a total of no more than 650 million yuan, which will be used for ferrite device production line construction projects, annual output of 7 million pieces of LCD TV metal stamping backplane projects, magnetic components research and development and industrialization projects and supplementary working capital.
Wanlang Magnetic: It is planned to raise no more than 296 million yuan from the controlling shareholder to supplement the working capital
Wanlang Magnetic Plastic (603150) announced on the evening of December 20 that the company intends to issue A-shares to specific objects to raise a total of no more than 296 million yuan, which will be used to supplement liquidity after deducting the issuance costs. The target of the issuance is Shi Qianzhong, the controlling shareholder and actual controller of the company. Shi Qianzhong intends to subscribe for all the shares issued in cash.
【Change in Shareholding】
Hongqi Chain: The controlling shareholder of the company intends to change to commercial investment and resume trading of shares
Hongqi Chain (002697) announced on the evening of December 20 that the actual controller Cao Shiru and his concerted actors intend to transfer their total 6.91% shares and their corresponding shareholder rights and interests to Sichuan Commercial Investment Investment Co., Ltd. (hereinafter referred to as Commercial Investment); The controlling shareholder of the company was changed to Commercial Investment Investment, and the actual controller of the company was changed to the State-owned Assets Supervision and Administration Commission of Sichuan Provincial Government. The company's shares have resumed trading since the market opened on Thursday, December 21.
Yonghui Supermarket: It is planned to sell 10% of the shares of Hongqi Chain to Sichuan Commercial Investment for 800 million yuan
Yonghui Supermarket (601933) announced on the evening of December 20 that Sichuan Commercial Investment intends to purchase 136 million shares of Hongqi Chain (002697) held by the company in cash, accounting for 10% of the total share capital of Hongqi Chain, with a transfer price of 5.88 yuan per share and a total transfer price of 800 million yuan. After the completion of the transaction, the company still holds 150 million shares of Hongqi Chain, accounting for 11% of the total share capital of Hongqi Chain.
Longzhou shares: planning to change the controlling shareholder and suspend the company's shares
Longzhou shares (002682) announced on the evening of December 20 that the company's controlling shareholder, Fujian Longyan Transportation State-owned Assets Investment and Management Co., Ltd. (hereinafter referred to as "Communications State Investment") is planning to transfer the equity of the listed company it holds, which may lead to a change in the company's controlling shareholder. The company's shares have been suspended since the market opened on December 21 (Thursday), and the suspension time is expected to be no more than two trading days.
Dasheng Culture: The controlling shareholder plans major events or changes the control of the company
Dasheng Culture (600892) announced on the evening of December 20 that the company received a notice from Zhou Zhenke, the controlling shareholder and actual controller, on December 20, that it was planning the equity transfer of the company, and the transfer object was Tangshan Cultural Tourism Investment Group Co., Ltd., which may lead to a change of control of the company. The company's shares have been suspended since the market opened on the morning of December 21 (Thursday), and the suspension is expected to last no more than two trading days.
【Major Investments】
Sichuan Investment Energy: It is planned to invest 8.263 billion yuan in the development of Yibin Pingshan Pumped Storage Power Station
Sichuan Investment Energy (600674) announced on the evening of December 20 that in order to further enhance the company's core competitiveness and influence in the field of clean energy, the company decided to invest 8.263 billion yuan (the total investment of the project), and set up a Pingshan pumped storage project company to be responsible for investing in the development of Yibin Pingshan pumped storage power station. The company intends to use cash + bank loan to make capital contributions, and gradually put it in place according to the progress of the project.
Jingjin Equipment: It is planned to invest 480 million yuan in the second phase of the industrialization project of complete sets of filtration equipment
Jingjin Equipment (603279) announced on the evening of December 20 that the company plans to invest 480 million yuan to build the second phase of the industrialization project of complete sets of filtration equipment, mainly producing filter press components. The total construction period of the project is expected to be 24 months, that is, from March 2024 to February 2026.
Golden Eagle Co., Ltd.: It is planned to set up a joint venture company to invest in the construction of a 30,000-spindle hemp spinning project in Vietnam
Golden Eagle Co., Ltd. (600232) announced on the evening of December 20 that the company plans to jointly invest in the establishment of an overseas joint venture company in Vietnam with Xinma Garment, a wholly-owned subsidiary of Shengtai Group, to build a research and development and production base for hemp products. The total investment of the proposed project of the joint venture is expected to be 51.243 million US dollars (equivalent to about 359 million yuan), which will be constructed and put into operation in two phases, with the production scale of 15,000 spindles in the first and second phases. After the construction of the project is completed and put into operation, it is expected to produce 5,400 tons of high-grade flax and hemp yarn per year.
Chuanzhi Education: It is planned to increase the capital of 290 million yuan to Datong Haoxue
Chuanzhi Education (003032) announced on the evening of December 20 that the company intends to increase its capital to its wholly-owned subsidiary, Datong Haoxue Education Technology Co., Ltd. (hereinafter referred to as "Datong Haoxue"), with its own funds of 290 million yuan. After the completion of this capital increase, the registered capital of Datong Haoxue has increased from 10 million yuan to 300 million yuan, and it is still a wholly-owned subsidiary of the company. The capital increase to the wholly-owned subsidiary Datong Haoxue is to meet the capital needs of the investment project of the funds raised by the issuance and the construction of Datong Internet Vocational and Technical College, and to ensure the smooth implementation of the investment project of the raised funds.
Gansu Nenghua: It plans to invest 210 million yuan to set up a wholly-owned subsidiary for electricity sales
Gansu Nenghua (000552) announced on the evening of December 20 that in order to effectively integrate the company's internal resources, improve the market competitiveness of power generation and consumption business, and promote the optimal allocation of power resources, the company plans to set up a wholly-owned subsidiary, Gansu Nenghua Power Sales Co., Ltd. (hereinafter referred to as "Power Sales Company") with 210 million yuan in cash. After the capital contribution, the company holds 100% of the equity of the electricity sales company.
Sunward: It plans to invest 150 million yuan to set up a wholly-owned subsidiary
Sunward Intelligent (002097) announced on the evening of December 20 that the company plans to invest 150 million yuan to set up a wholly-owned subsidiary, Hunan Sunward Mining Equipment Co., Ltd. The main purpose of the establishment of a wholly-owned subsidiary, Sunward Mineral, is to develop Sunward's intelligent mining equipment business with Sunward Minerals as the main body, which is more conducive to the field of rock drilling equipment to become more refined, stronger and bigger, and is conducive to further improving the company's mining equipment business layout, which is in line with the company's actual business needs.
Neway shares: plans to set up a Saudi subsidiary for 8 million US dollars
Neway (603699) announced on the evening of December 20 that the company intends to set up a wholly-owned subsidiary, Neway Petroleum Equipment (Saudi) Co., Ltd. (proposed name, subject to the final approval of relevant departments) through the company's subsidiary Neway Petroleum Equipment (Suzhou) Co., Ltd., in Saudi Arabia, and intends to invest about 8 million US dollars in its own funds, mainly used for local plant leasing, plant decoration, equipment investment, software investment, preparation fees, working capital and other local capacity construction related investment.
Zhongchen Co., Ltd.: It plans to jointly invest 11 million yuan with Xinglin Technology to establish a joint venture company in the field of computing power services
Zhongchen Co., Ltd. (300933) announced on the evening of December 20 that based on the optimism about the development prospects of intelligent computing services and related business fields, the company signed the "Investment Agreement" with Hangzhou Xinglin Technology Co., Ltd. (hereinafter referred to as "Xinglin Technology"), and the two parties agreed to jointly invest in the establishment of a joint venture company, with a registered capital of 11 million yuan, of which the company subscribed 7.7 million yuan, accounting for 70% of the total capital contribution.
【Winning Contract】
Johnson shares: obtained the customer's project fixed-point notice
Johnson Co., Ltd. (605555) announced on the evening of December 20 that the company recently received a fixed-point notice from Nexteer North America on the project of EPS motors. According to the customer's plan, the life cycle of the fixed-point project is 10 years, and the total sales amount of the life cycle is expected to be about 143 million US dollars, and it is expected to gradually start mass production in May 2025.
Yinlun Co., Ltd.: The subsidiary was designated as a new energy vehicle air-conditioning box project by a well-known European auto parts manufacturer
Yinlun Co., Ltd. (002126) announced on the evening of December 20 that its wholly-owned subsidiary, Shanghai Yinlun Heat Exchange System Co., Ltd., recently received a fixed-point notice from a well-known European auto parts manufacturer. The company obtained the designation of the customer's new energy vehicle air-conditioning box project. The project has a life cycle of 8 years and is expected to start mass production in May 2026. According to customer forecasts, sales are expected to be around 82.1 million euros over the life cycle.
Han Jianheshan: Won the bid of 517 million yuan for the pipeline procurement project of the second phase of the Yangtze River and Huai River Project
Han Jianheshan (603616) announced on the evening of December 20 that the company won the bid for "2 bids for pipeline procurement of the second phase of the Yangtze River and Huai River Diversion Project (water conservancy part)" with 517 million yuan, accounting for about 92.79% of the company's audited operating income in 2022.
China Construction Construction: Recently won the bid for 3 projects
China Construction (002822) announced on the evening of December 20 that the company recently received the "Notice of Winning the Bid" from the Construction and Public Works Department of Luohu District, Shenzhen, Shenzhen Metro Qianhai International Development Co., Ltd. and Hebei Shenbao Investment and Development Co., Ltd., confirming that the company was the winning bidder of the "fine decoration and garden landscape of the new project of the full boarding high school of Luohu Foreign Chinese School", "the concentrated commercial fine decoration project of the No. 1 plot of Shenzhen Railway Yifu", and the "fine decoration project construction (secondary) of the public area of Shenzhen Yuanyan Huacheng Project". The winning bids were 84.8637 million yuan, 52.3802 million yuan and 46.9123 million yuan respectively.
Zhimingda: Obtained 133 million yuan of customer task demand orders
Zhimingda (688636) announced on the evening of December 20 that the company recently received orders from customers for related tasks, with a total amount of about 133 million yuan (including tax), accounting for 24.58% of the company's audited operating income in the most recent fiscal year. The subject matter of the task demand order is the airborne embedded computer, missile embedded computer, and vehicle-mounted embedded computer related modules.
Saifutian: The holding company signed a framework contract for the daily sales of cells
Saifutian (603028) announced on the evening of December 20 that the company's holding company, Anhui Meidalun, signed a framework contract for the daily sales of cells with Jiangsu Phono Solar Technology Co., Ltd. (hereinafter referred to as "Phono Solar"). The contract stipulates that from December 19, 2023 to December 31, 2026, Anhui Medalun will supply a total of 4.5GW of TOPCon monocrystalline cells to Phono Solar, and the specific settlement price shall be subject to the corresponding transaction amount of the orders signed by the two parties under this contract.
Plitt signed a cooperation agreement with Lunnai on the procurement of LCP film products
Plitt (002324) announced on the evening of December 20 that the company recently reached an agreement with Shanghai Lunnai New Material Technology Co., Ltd. (hereinafter referred to as "Lunnai") on the commercial orders of the company's high-performance LCP film in the sales of electric connection technology Co., Ltd., Shenzhen Xinwei Communication Co., Ltd., Taihong Technology Co., Ltd. and Lianmao Electronics Co., Ltd. and signed the "Strategic Procurement Cooperation Agreement". This agreement will have a positive impact on the large-scale sales of the company's LCP business, which will facilitate the rapid development of the company's ICT business and have a positive impact on the company's future performance.
[Others]
Xinhua Insurance: The qualifications of the chairman of the board of directors were approved by the State Administration of Financial Regulation
Xinhua Insurance (601336) announced on the evening of December 20 that the company recently received the "Reply on the Qualifications of Yang Yucheng of Xinhua Life Insurance Co., Ltd." from the State Administration of Financial Regulation, which has approved Yang Yucheng's qualifications as the chairman of the company.
Sichuan Meifeng: All production lines of the polymer materials industrial park project have been completed and put into trial operation
Sichuan Meifeng (000731) announced on the evening of December 20 that all production lines of the polymer material industrial park project invested and constructed by Sichuan Meifeng Polymer Materials Technology Co., Ltd., a wholly-owned subsidiary, in Shehong Economic Development Zone, Sichuan Province, have been completed and put into trial operation. Among them, 2 cast functional film production lines, 2 heavy-duty film (FFS film) production lines have been put into trial production, and 1 all-PE structure oxide plating barrier film production line is organizing sample production.
Yusys Technologies: Signed a strategic cooperation agreement with Xiamen Asset Management
Yusys Technologies (300674) announced on the evening of December 20 that the company and Xiamen Asset Management Co., Ltd. (hereinafter referred to as "Xiamen Asset Management") signed the "Strategic Cooperation Agreement between Beijing Yusys Technology Group Co., Ltd. and Xiamen Asset Management Co., Ltd.", and the two sides negotiated to establish a strategic partnership in the field of personal loan non-performing assets to create a benchmark combination of finance + technology.
Yinzhijie: Signed a strategic cooperation framework agreement with Hunan Xiangjiang Financial Technology Service Co., Ltd
Yinzhijie (300085) announced on the evening of December 20 that the company signed a strategic cooperation framework agreement with Hunan Xiangjiang Financial Technology Service Co., Ltd. to jointly explore product innovation based on the application of public data in the financial industry and provide customized differentiated financial application scenario products for financial enterprises.
Jiuqiang Biotech: Sun Company entered into a product distribution agreement with ELITechGroup Inc
Jiuqiang Biotech (300406) announced on the evening of December 20 that Sun Company signed a "Product Distribution Agreement" with ELITechGroup Inc., a Utah company, agreeing that from December 14, 2023 to December 14, 2028, EGI will purchase the fully automatic immunohistochemical staining systems Titan and TitanS, as well as related supporting detection reagents and cleaning solutions, from Maixin Biotech. During the term of the agreement, EGI has the exclusive right to distribute the product in the authorized territory.
Zhangjiajie: 6.32% of the company's shares held by the controlling shareholder Concerted Action Person Industrial Company were frozen by the judiciary
Zhangjiajie (000430) announced on the evening of December 20 that 25,577,200 shares of the company (accounting for 6.32% of the company's total share capital) held by Zhangjiajie Wulingyuan Tourism Industry Development Co., Ltd. (hereinafter referred to as the "industrial company"), the controlling shareholder acting in concert, were judicially frozen by the Saihan District People's Court of Hohhot City. The freezing of shareholders' shares will not affect the company's production and operation. Industrial companies are actively lifting the freeze on shares by replacing them with other property preservation measures to eliminate adverse effects.
Youche Technology: plans to purchase office buildings for 179 million yuan
Youche Technology (688479) announced on the evening of December 20 that the company intends to purchase the T1 single-family office building and supporting parking spaces of the second phase of Shanghai Changfeng Center located at No. 1 and 12, Lane 276, Luding Road, Shanghai, from Chengling Industry, with a total construction area of 4670.29 square meters. The total price of the subject matter of this transaction is 179 million yuan, and the source of funds is part of the raised funds and the company's own funds.
Hengrui Pharmaceutical: Obtained approval for two drug clinical trials
Hengrui Pharmaceutical (600276) announced on the evening of December 20 that the company received the approval of the State Food and Drug Administration to issue the "Notice of Approval of Drug Clinical Trials" on SHR0302 sustained-release tablets, and will carry out clinical trials for the indication of systemic lupus erythematosus in the near future. In addition, the company received the approval of the State Food and Drug Administration to issue the "Notice of Approval for Drug Clinical Trials" for SHR2554 tablets, and will soon carry out clinical trials of combination with CHOP/CHOEP or CD20 monoclonal antibody-based treatment regimens for mature lymphocytic tumors.
Nhwa Pharmaceutical: The U.S. FDA closed the warning letter to the company's Jiawang API factory
Nhwa Pharmaceutical (002262) announced on the evening of December 20 that on September 25, 2019, the company received a warning letter issued by the U.S. Food and Drug Administration ("FDA") in response to the deficiencies in the implementation of USP (United States Pharmacopeia) methods and standards found in the API inspection results of the company's Jiawang API factory from April 1 to 5, 2019. Recently, the company received an official email notification from the FDA that the FDA has completed the evaluation of the corrective measures for the deficiencies proposed in the company's warning letter dated September 10, 2019, and believes that the company has taken corresponding corrective actions for the deficiencies raised in the warning letter, and therefore, the warning letter to the company's Jiawang API factory has been closed.
Zhongguancun: Duoduo Pharmaceutical Montmorillonite Powder obtained the drug registration certificate
Zhongguancun (000931) announced on the evening of December 20 that the company's subsidiary, Duoduo Pharmaceutical Co., Ltd., received the "Drug Registration Certificate" with the certificate number 2023S02007 approved and issued by the State Food and Drug Administration, and the "montmorillonite powder" developed by Duoduo Pharmaceutical (specification: 3 grams of montmorillonite per bag) passed the generic drug registration application.
Warner Pharmaceutical: Diclofenac sodium sustained-release tablets passed the consistency evaluation of generic drug efficacy
Huana Pharmaceutical (688799) announced on the evening of December 20 that the company received the "Notice of Approval of Drug Supplementary Application" approved and issued by the State Food and Drug Administration for diclofenac sodium sustained-release tablets. Diclofenac sodium extended-release tablets are suitable for relieving rheumatoid arthritis and osteoarthritis.
Zhifei Biotech: The subsidiary's diphtheria-tetanus-pertussis vaccine entered phase III clinical trials
Zhifei Biotech (300122) announced on the evening of December 20 that the adsorbed cell-free diphtheria-pertussis (component) combination vaccine independently developed by Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd., a wholly-owned subsidiary, carried out phase III clinical trials in Guangxi. Diphtheria, tetanus, tetanus, and pertussis vaccine is a combination vaccine against pertussis, diphtheria, and tetanus.
CanSino: Initiated phase I clinical trial of adsorbed tetanus vaccine and completed the enrollment of the first subject
CanSino (688185) announced on the evening of December 20 that the company's adsorbed tetanus vaccine officially launched the phase I clinical trial recently and completed the enrollment of the first subject. This vaccine is mainly used for the prevention of non-neonatal tetanus, which will further enrich the company's product pipeline and enhance the company's core competitiveness.
China Pharmaceutical: The subsidiary's drugs passed the consistency evaluation of generic drugs
China Pharmaceutical (600056) announced on the evening of December 20 that Sanyo Pharmaceutical, a wholly-owned subsidiary of the company, received a "Notice of Approval of Drug Supplementary Application" for amoxicillin granules approved and issued by the State Food and Drug Administration, and the drug passed the consistency evaluation of generic drug quality and efficacy.
Anglikang: The subsidiary isoflurane (for pets) obtained the approval number of veterinary drug products
Anglikang (002940) announced on the evening of December 20 that recently, the company's subsidiary, Zhejiang Anglikang Animal Protection Technology Co., Ltd., obtained the approval number of "isoflurane (for pets)" veterinary drug products. Isoflurane (for pets) is an inhalation anesthetic used for anesthesia induction and maintenance of pet surgery.
Lifang Pharmaceutical: The company's metformin glipizide tablets passed the consistency evaluation of generic drug quality and efficacy
Lifang Pharmaceutical (003020) announced on the evening of December 20 that the company's metformin glipizide tablets passed the consistency evaluation of generic drug quality and efficacy. Metformin glipizide tablets are a combination preparation of metformin and glipizide, which is suitable for patients with type II diabetes who cannot fully and effectively control blood sugar through diet and exercise therapy.
![The Market Supervision and Administration Bureau of Yanta District carried out special sampling inspections of online ready-to-eat food distribution[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)